author-photo

Brittany Vo-Le

Baylor College of Medicine

6

Papers

13

Citations

Citation Trend

Filter By

Papers (6) Sort By

Journal Conference Others

Does mismatch negativity have utility for NMDA receptor drug development in depression

2021 Revista Brasileira de Psiquiatria
Show All
- Source
- Cite
- Save
Citations (1)
Impact of the KCNQ2/3 Channel Opener Ezogabine on Reward Circuit Activity and Clinical Symptoms in Depression: Results From a Randomized Controlled Trial.

2021 American Journal of Psychiatry
Show All
- Source
- Cite
- Save
Citations (0)
Neurophysiological and clinical effects of the NMDA receptor antagonist lanicemine (BHV-5500) in PTSD: A randomized, double-blind, placebo-controlled trial.

2021 Depression and Anxiety
Show All
- Source
- Cite
- Save
Citations (1)
A randomized cross-over trial to define neurophysiological correlates of AV-101 N-methyl-d-aspartate receptor blockade in healthy veterans

2020 Neuropsychopharmacology
Show All
- Source
- Cite
- Save
Citations (3)
Cortical Gamma as a Marker of Kynurenine Pathway Engagement in Healthy Veterans Receiving L-4-Chloro-Kynurenine (AV-101)

2020 Biological Psychiatry
Show All
- Source
- Cite
- Save
Citations (0)
A Proof-of-Mechanism Study to Test Effects of the NMDA Receptor Antagonist Lanicemine on Behavioral Sensitization in Individuals With Symptoms of PTSD

2019 Frontiers in Psychiatry
Show All
- Source
- Cite
- Save
Citations (8)